You are here

Home » Content

Kolonoskopi Sonrası Görülen Akut Fosfat Nefropatisi Olgusu

A Case of Acute Phosphate Nephropathy After Colonoscopy

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2013
DOI: 
DOI 10.5262/tndt.2013.1001.19

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Acute phosphate nephropathy is a form of acute kidney injury (AKI) due to oral sodium phosphate (ONaP) purgatives used for bowel cleansing before colonoscopy. Usually, 45 ml ONaP is given two times daily 12-24 hours prior to colonoscopy. Intestinal absorption is followed by transient hypocalcemia and hyperphosphatemia in almost all patients. In addition, severe hyperphosphatemia, symptomatic hypocalcemia, hypernatremia, hypocalcemia, hyponatremia, hypokalemia, high anion gap metabolic acidosis and AKI can be seen. The patient presented in this paper is a 65-year-old female. She was diagnosed with type 2 diabetes mellitus and hypertension. Colonoscopy was performed in order to investigate the etiology of iron deficiency anemia. ONaP was administered for preparation of colonoscopy and AKI which was clinically compatible with APN developed after the procedure.
Bookmark/Search this post with
Abstract (Original Language): 
Akut fosfat nefropatisi (APN) kolonoskopi öncesi bağırsak temizliği için kullanılmakta olan oral sodyum fosfat (ONaP) içeren purgatiflere bağlı görülen bir akut böbrek hasarı formudur. Genellikle kolonoskopi yapılacak olan hastalara işlemden 12-24 saat önceden başlayarak iki kez 45 ml’lik ONaP verilmektedir. İntestinal emilim olmakta ve geçici hiperfosfatemi ile hipokalsemi hemen her hastada görülmektedir. Bunun yanı sıra ciddi hiperfosfatemi, semptomatik hipokalsemi, hipernatremi, semptomatik hiponatremi; hipokalemi, yüksek anyon açıklı metabolik asidoz ve akut böbrek hasarı (ABH) görülebilmektedir. Bu yazıda sunulan olgu 65 yaşında kadın olup tip 2 diyabet ve hipertansiyon tanıları mevcuttu. Demir eksikliği anemisinin etiyolojisinin araştırılması amacıyla kolonoskopi yapılmıştı. ONaP ile kolonoskopi hazırlığı yapılmış ve işlem sonrası klinik olarak APN ile uyumlu ABH gelişmişti.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_22_pp_117-119.pdf
  • 1
117-119
  • Turkish

REFERENCES

References: 

1. Balaban DH: Guidelines for the safe and effective use of sodium
phosphate solution for bowel cleansing prior to colonoscopy.
Gastroenterol Nurs 2008; 31 (5): 327-334
2. Pálmadóttir VK, Gudmundsson H, Hardarson S, Arnadóttir M,
Magnússon T, Andrésdóttir MB: (2010) Incidence and outcome of
acute phosphate nephropathy in Iceland. PLoS ONE 2010; 5 (10):
e13484
3. Aydınlı F, Ahıshalı E, Dolapçıoğlu C, Uygur MM, Dabak R:
Evaluation of the safety and afficacy of colonoscopy preparation by
sodium phosphate in patients with normal creatinin values. J Kartal
TR 2011; 22 (3): 113-120
4. Lieberman DA, Ghormley J, Flora K: Effect of oral sodium
phosphate colon preparation on serum electrolytes in patients with
normal serum creatinine. Gastrointest Endosc 1996; 43 (5): 467-469
5. Gumurdulu Y, Serin E, Ozer B, Gokcel A, Boyacioglu S: Age
as a predictor of hyperphosphatemia after oral phosphosoda
administration for colon preparation. J Gastroenterol Hepatol 2004;
19 (1): 68-72
6. Markowitz GS, Stokes MB, Radhakrishnan J, D’Agati VD: Acute
phosphate nephropathy following oral sodium phosphate bowel
purgative: An underrecognized cause of chronic renal failure. J Am
Soc Nephrol 2005; 16 (11): 3389-3396
7. Barclay RL: Safety, efficacy, and patient tolerance of a three-dose
regimen of orally administered aqueous sodium phosphate for
colonic cleansing before colonoscopy. Gastrointest Endosc 2004;
60 (4): 527-533
8. Hookey LC, Depew WT, Vanner S: The safety profile of oral
sodium phosphate for colonic cleansing before colonoscopy in
adults. Gastrointest Endosc 2002; 56 (6): 895-902
9. Markowitz GS, Whelan J, D’Agati VD: Renal failure following
bowel cleansing with a sodium phosphate purgative. Nephrol Dial
Transplant 2005; 20 (4): 850-851
10. Lien YH: Are oral sodium phosphate products for bowel cleansing
safe for the general population? Am J Med 2008; 121 (11): 931-932
11. Ori Y, Herman M, Tobar A, Chernin G, Gafter U, Chagnac A, Izhak
OB, Korzets A: Acute phosphate nephropathy-an emerging threat.
Am J Med Sci 2008; 336 (4): 309-314

Thank you for copying data from http://www.arastirmax.com